Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038597
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2002-06-03
Brief Title:
Phase II Study of SCH66336 A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia CML
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2004-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2002-06-03
First Submit QC Date:
June 3 2002
Study First Post Date:
2002-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-29
Last Update Post Date:
2018-10-30
Last Update Post Date Type:
ACTUAL